South Cone Investments Limited Partnership, 10% Owner at Rani Therapeutics Holdings, Inc. (RANI), bought 1,850 shares at $5.37 ($10K) on 2023-04-18, disclosed to the SEC on 2023-04-20.
Open-market purchase of $10k RANI by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| Filing → |
| RANI | BUY | 2023-12-08 | $21.2M | — | Filing → |
| RANI | BUY | 2023-05-05 | $10K | — | Filing → |
| RANI | BUY | 2023-05-02 | $10K | — | Filing → |